| Hemo Organic Ltd | Industry : (Trading) | |
|---|---|---|
|
BSE Code : 524590 |
NSE Symbol : - |
P/E(TTM) : 39.27 |
|
ISIN Demat : INE422G01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.37 |
|
Book Value(₹) : -0.76 |
Market Cap(₹Cr) : 5.04 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 2.41 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 2.41 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.00 | 0.00 | 2.50 | 0.00 | 0.00 | 0.00 |
| Total Expenditure | 0.04 | 0.12 | 2.27 | 0.13 | 0.08 | 0.00 |
| PBIDT | -0.04 | -0.11 | 0.24 | -0.13 | -0.08 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -0.04 | -0.11 | 0.24 | -0.13 | -0.08 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | -0.03 | -0.14 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.03 | -0.09 | 0.37 | -0.13 | -0.08 | 0.00 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.03 | -0.09 | 0.37 | -0.13 | -0.08 | 0.00 |
| EPS (Unit Curr.) | -0.09 | -0.25 | 1.08 | -0.37 | -0.23 | -0.01 |
| EPS (Adj) (Unit Curr.) | -0.09 | -0.25 | 1.08 | -0.37 | -0.23 | -0.01 |
| Calculated EPS (Unit Curr.) | -0.09 | -0.25 | 1.08 | -0.37 | -0.23 | -0.01 |
| Calculated EPS (Adj) (Unit Curr.) | -0.09 | -0.25 | 1.08 | -0.37 | -0.23 | -0.01 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.36 | -0.99 | 4.31 | -1.47 | -0.91 | -0.04 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.36 | -0.99 | 4.31 | -1.47 | -0.91 | -0.04 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 |
| Reserve & Surplus | -3.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 9.96 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 0.00 | 0.00 | 9.96 | 0.00 | 0.00 | 0.00 |
| PATM(%) | 0.00 | 0.00 | 15.35 | 0.00 | 0.00 | 0.00 |